期刊
JOURNAL OF SURGICAL ONCOLOGY
卷 109, 期 4, 页码 314-319出版社
WILEY-BLACKWELL
DOI: 10.1002/jso.23554
关键词
melanoma; intralesional therapy; treatment
Rose Bengal is a novel injectable agent that has been evaluated as a rational treatment strategy for melanoma patients with recurrent unresectable local/regional metastases accessible for intralesional injection. PV-10 (10% Rose Bengal) has completed phase 1 and phase 2 multi-center clinical trials demonstrating significant local/regional disease control and also responses in non-injected regional bystander lesions and distant metastases. The published results of studies that have assessed PV-10 are presented, and the rationale for combining its use with recently approved immunotherapeutic agents is discussed. J. Surg. Oncol. 2014 109:314-319. (c) 2014 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据